StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CLPT

ClearPoint Neuro, Inc.

CLPT Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$15.38
+0.80 +5.49%

Key statistics

from XBRL data in SEC filings
Market cap
$469M
Revenue (TTM)
$42.3M
Net income (TTM)
-$34.6M
EPS (TTM)
$-1.17
P/E ratio
Dividend yield
Free cash flow
-$24.4M
Cash
$29.4M
Total assets
$86.7M
Gross margin
62.6%
52-week range
$8.27 – $30.10

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Aug 3, 2026 8-K Director or officer change; Shareholder vote results May 21, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 17, 2026 8-K/A Feb 5, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jan 5, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Regulation FD disclosure Nov 20, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 6, 2025 8-K Entered a material agreement; Regulation FD disclosure Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2025 8-K Entered a material agreement Jun 17, 2025 8-K Director or officer change; Shareholder vote results May 23, 2025 8-K Other events May 19, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 13, 2025 8-K Entered a material agreement; Other events May 12, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 26, 2025 8-K Entered a material agreement Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 7, 2024 8-K Regulation FD disclosure Aug 26, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 7, 2024 8-K Director or officer change; Shareholder vote results May 16, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2024 10-K Fiscal year ended 2023-12-31 Mar 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 12, 2024 8-K Entered a material agreement Mar 1, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 9, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023